Share Price:

APNASPENAspen Pharmacare Hldgs1493232 (0.21%)

Aspen is in a closed period from 1st July 2026 until the publication of the annual results on the JSE SENS platform on the 2nd September 2026.

Keeping technology focused on what matters most – People and purpose

Technology should never be pursued for its own sake. Its true value lies in helping people work more effectively, solve real business challenges and support strategic priorities.

Strengthening partnerships, visibility and sustainable progress in the CDMO space

Screenshot

Aspen API recently participated in CDMO Live Europe 2026 in Rotterdam, Netherlands — an important platform that brought together leading pharmaceutical organisations, CDMOs and industry stakeholders for focused engagement, networking and business development.

From Support to Success: Joeline Moodley’s Career Journey

At Aspen, we believe that when our people grow, our business grows too. That is why it is always especially meaningful to celebrate career milestones that reflect the power of development, opportunity, and recognising potential from within.

Developing future capability starts with investing in people

Screenshot

That commitment was recently brought to life through the participation of our Group Regulatory Specialist, Nabila Essack, in an international training and development programme focused on vaccine manufacturing and regulation.

Aspen leader highlights importance of skills, collaboration and technology in driving manufacturing competitiveness

In a recent opinion piece published in The Herald, Branson Bosman, Executive: Workforce Development & Strategic Engagement, Aspen South Africa Operations, shared his views on the critical role that skills development, industry collaboration and investment in technology play in strengthening South Africa’s manufacturing competitiveness.

Aspen Athletics Club delivers inspiring performance at the Comrades Marathon

The Comrades Marathon, known around the world as the Ultimate Human Race, once again tested athletes to their limits this June, with its demanding up run. Covering 85.777 kilometres from Durban to Pietermaritzburg in South Africa, and climbing approximately 2,000 metres in elevation, the race remains a true test of endurance, resilience and determination.

Aspen API was pleased to participate in TIDES US 2026 in Boston in May

As a leading forum for the peptide and oligonucleotide sector, the symposium provided a valuable platform to engage with potential partners, stay abreast of technical and regulatory developments, and connect with key industry stakeholders shaping the future of complex modalities.

What does practical sustainability in API manufacturing really look like?

It starts with the actions that can make a measurable difference today.

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: